Delivery Order 36F79724D0101-36C24226N0741
Award Date 8/27/26
Potential Completion Date 10/31/26
Potential Value $364K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lawrenceville, Lawrence Township, NJ 08648, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 9, on behalf of the Department of Veterans Affairs, issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on September 11, 2026, for BREYANZI injection (lisocabtagene maraleucel), a chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma. The order is placed under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award IDIQ vehicle with a ceiling value of $12.278 billion extending through April 30,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22, issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 30, 2026, for BREYANZI (lisocabtagene maraleucel), a chimeric antigen receptor T cell therapy, under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The GSA FSS-61-IB is a multiple-award IDIQ vehicle with a $12.278 billion ceiling extending through April 30, 2029, supporting specialized oncology and hematology...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI (lisocabtagene maraleucel) CAR T cell therapy under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is priced firm fixed price with no set-aside. Place of performance is Lawrenceville, New Jersey. The order is due for completion on September 17, 2026. The parent FSS vehicle, Pharmaceuticals and Drugs (FSS-61-IB), is a...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI CAR T cell therapy for transplant under the Department of Veterans Affairs Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The order is firm fixed price with no set-aside designation. Place of performance is Lawrenceville, New Jersey, with an ultimate completion date of September 17, 2026. BREYANZI (lisocabtagene maraleucel) is a...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 18, 2026, for BREYANZI CAR T transplant therapy under the Department of Veterans Affairs' Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The order carries a firm fixed-price structure with no set-aside designation. Place of performance is Lawrenceville, New Jersey, with an ultimate completion date of September 17, 2026. BREYANZI (lisocabtagene maraleucel)...
- The Department of Veterans Affairs, Veterans Integrated Service Network 9, issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 26, 2026, for BREYANZI CAR-T transplant therapy under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The parent vehicle is Bristol-Myers Squibb's Federal Supply Schedule contract for pharmaceuticals and drugs, a multiple-award indefinite delivery/indefinite quantity vehicle with a ceiling of $12.278 billion extending through April 30,...
- Veterans Integrated Service Network 9 issued a $364,139.25 delivery order to Bristol-Myers Squibb Company on June 11, 2026, for BREYANZI CAT-T transplant therapy, with final completion scheduled for September 1, 2026. The order is issued under Bristol-Myers Squibb's Federal Supply Schedule contract (36F79724D0101) covering Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award indefinite delivery/indefinite quantity vehicle with a $12.278 billion ceiling extending through April 30, 2029....
- Bristol-Myers Squibb Company has been awarded a delivery order valued at $335,042.65 by Veterans Integrated Service Network 9 (VISN 9), a civilian component of the Department of Veterans Affairs, for the supply of BREYANZI CAR T cell therapy. This firm fixed-price delivery order, awarded on January 21, 2026, with an ultimate completion date of April 30, 2026, represents a child contract issued under Bristol-Myers Squibb's existing Federal Supply Schedule contract for Pharmaceuticals and Drugs...
- Bristol-Myers Squibb Company received a delivery order modification worth $39,717.46 for ABECMA (idecabtagene vicleucel), a chimeric antigen receptor T cell therapy used to treat multiple myeloma and other hematologic malignancies. This delivery order, awarded on March 13, 2026, carries a total ceiling value of $378,650.30 and is scheduled for completion by September 12, 2026. The order was issued by Veterans Integrated Service Network 9 through Bristol-Myers Squibb's existing Federal Supply...
- Veterans Integrated Service Network 9 issued a $378,650.30 delivery order to Bristol-Myers Squibb Company on August 10, 2026, for ABECMA injection under the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The parent vehicle is the GSA Federal Supply Schedule (FSS-61-IB), a multiple-award IDIQ with a $12.278 billion ceiling extending through April 30, 2029. Place of performance is Lawrenceville, Lawrence Township, NJ. The order is firm fixed price with an ultimate...